2nd Beijing Forum on High-Quality Clinical Research Development in the Medical and Health Industry 2023

To thoroughly implement the spirit of the 20th National Congress of the Communist Party of China and promote the coordinated development and governance of medical insurance, healthcare services, and pharmaceuticals, this event is guided by the Administrative Committee of Zhongguancun Life Science Park, jointly organized by Beijing Zhongguancun Life Science Park Development Co., Ltd. and Beijing Qianfan Xinchuang Medical Health Technology Center, with VCBeat serving as the exclusiveCollaborationVCBeat’s “2nd Beijing Pharmaceutical and Health Industry High-Quality Development Forum on Clinical Research” will be held at the Taikang Institute of Study from June 14 to June 16, 2023.

As healthcare system reforms continue to deepen, the pharmaceutical and health industry market has undergone significant changes, with a strong emphasis on clinical practice and robust R&D becoming the driving force and source of industrial development. This forum will adhere to the principle of “patient-centricity and value orientation,” focusing on R&D strategies for drugs and medical devices guided by clinical value, thereby promoting high-quality development of the pharmaceutical and health industry. The forum will cover topics including national policies and regulations; case studies demonstrating how cutting-edge clinical research facilitates the market launch of innovative drugs and medical devices; new advances in innovative therapies and diagnostic/treatment technologies; research into innovative drugs and medical devices driven by unmet clinical needs; and practical training on quality management in clinical trials (covering protocol design, organization and implementation, monitoring, auditing, record-keeping, data analysis and summarization, and reporting). Government agencies, clinical experts, and experts from clinical trial institutions are invited to participate.

VCBeat (a brand under Danhuang Technology) is an innovative industry service provider that leverages data as its foundation, research as its core, and brand media as its connector to facilitate the precise aggregation of industrial resources and accelerate the growth of industry changemakers. Focusing on the life and health sector, VCBeat, together with its affiliated brands VB100, VCBeat Research Institute, and VCBeat Orange, provides services such as brand communication, research consulting, data monitoring, and resource/project matchmaking for enterprises, government industrial parks, investment institutions, and other entities across the industry chain. Since its establishment in 2014, we have published over 21,000 medical articles and more than 500 original industry reports, covered nearly 10,000 companies, built a database of over 170,000 enterprises, and successfully hosted seven editions of the Future Healthcare Top 100 Conference. It has become the preferred interactive platform for innovation, entrepreneurship, investment, and corporate development.

Since its establishment, the company has secured investments from multiple renowned investment firms, including Legend Capital, BV Baidu Ventures, Honghui Capital, Changling Capital, Yifang Group, and Weilai Capital, achieving a valuation of several hundred million RMB.